Cookies not enabled?
The Movember website requires cookies
Please enable cookies on your browser
“When my dad was diagnosed with prostate cancer I felt powerless.”
Read Andrew & Dave’s story

“I think everybody believes they’re going to live forever, even though they know they won’t. Nobody wants to be told, as I was last year, that they have five to seven years to live.”
Hear Jim’s story
Prostate cancer is the second most common cancer in men globally. More than 1.3 million men are diagnosed with prostate cancer each year.
Across New Zealand, there are more than 13,500 men living with and beyond prostate cancer. Many are dealing with serious side effects from treatment.
IT DOESN’T HAVE TO BE LIKE THIS.
So we’re taking action.
We’ve spent years immersed in prostate cancer research, and in that time, we’ve pushed progress forward 50 years. How? By thinking differently, collaborating globally and investing quickly in what works.
By 2030 ...
We aim to halve the number of men dying from prostate cancer, and halve the number of men facing serious ongoing side effects from treatment.
“I'd like to imagine my son growing up in a world where prostate cancer can be cured. In a world where the way Dad freely talked about his health and his regular health checks isn’t unique, but the norm.”
Read Charlotte's story
This is how we’re going to win the fight.
Our weapons of choice? Innovation and collaboration. We think differently. We back fresh and promising ideas. We unite researchers and experts across the world to chase down breakthroughs in prostate cancer, from early detection through to diagnosis, treatment and support. And we’re always steered by the question: what works for men?
It’s not just about a cure – it’s about quality of life.
The plan of attack
1. Taking action early
Helping men know the signs, symptoms and risk factors for prostate cancer.
2. Bright minds brought together
We’re bringing the best minds from around the world together to collaborate.
3. Tackling biology
Increasing the knowledge of the most lethal prostate cancer tumours, and how to slow or stop its progression.
4. Reducing side effects
No matter where they are in the world, men and their families and carers must have access to services and support.
5. Affordable treatment
We’re influencing governments to provide affordable treatment and to get new treatments into practice faster.
6. Tailored treatments, precision care
Personalised treatment is the new frontier of cancer research. From distinguishing between harmless and lethal cancers, to taking into account genes, lifestyle and environment: it means a better outcome for men.
7. Helping men make tough choices
Men need the right info to understand their diagnosis and make an informed decision when it comes to treatment.
8. Raising the standard
We’re identifying excellence in prostate cancer treatment and care, to reduce the number of men who aren’t getting the best outcome possible.
9. Global initiatives
Our three largest investments in prostate cancer are global projects that will mean better outcomes for men everywhere.
GLOBAL COLLABORATION
The key to progress? Collaboration. We connect researchers around the world, achieving faster results to reach men sooner. We share our successes and our failures so the scientific community doesn’t lose time to duplicating research.
Global Action Plan
Movember works with leading researchers from around the world to identify key research areas to work together on. Since 2011, Movember has committed $43 million AUD to seven key global research projects in prostate and testicular cancer:
- GAP1: Prostate Cancer Biomarkers
- GAP2: Advanced Prostate Cancer Imaging
- GAP3: Prostate Cancer Active Surveillance
- GAP4: Prostate Cancer Exercise and Metabolic Health
- GAP5: Testicular Cancer TIGER Trial
- GAP6: Oligometastic Prostate Cancer
- GAP7: True North Testicular Cancer Program